Granules India Ltd - GRANULES INDIA Share Price

Sector: Pharmaceuticals | ISIN: INE101D01020
₹ 411.35 (-0.80%) icon19 Apr, 2024, 12:00:00 AM

Granules India Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 4/19/2024 12:00:00 AM

    ₹ 411.35 -3.30 -0.80
  • Open
  • ₹ 411
  • Prev. Close
  • ₹ 414.65
  • Turnover(Lac.)
  • ₹ 2,421
  • Day's High
  • ₹ 413.55
  • Day's Low
  • ₹ 404.4
  • 52 Week's High
  • ₹ 480.45
  • 52 Week's Low
  • ₹ 272.35
  • Book Value
  • ₹ 125.35
  • Face Value
  • ₹ 1
  • Mkt Cap (₹ Cr.)
  • 9,969.84
  • P/E
  • 21.47
  • EPS
  • 19.14
  • Divi. Yield
  • 0.36

Granules India Ltd Corporate Actions

10 Jan , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

10 Jan , 2024

12:00 AM

27 Oct , 2023

12:00 AM

27 Oct , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

16 May , 2023

12:00 AM

AGM

Announcement date: 16 May , 2023

View Details

26 Jul , 2023

12:00 AM

26 Jul , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

16 May , 2023

12:00 AM

Dividend

Dividend amount: 1.5
Announcement date: 16 May , 2023

View Details

24 Apr , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

24 Apr , 2023

12:00 AM

17 May , 2023

12:00 AM

BookCloser

View Details

No Record Found


Granules India Ltd News and Update

No Record Found

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Granules India Ltd SHAREHOLDING SNAPSHOT
21 April , 2024 | 12:21 AM

PROMOTER - TOTAL41.96%

Indian: 41.61%

Foreign: 0.3531%

NON-PROMOTER - TOTAL 58.04%

Institutions: 30.27%

Non-Institutions: 27.76%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Granules India Ltd FINANCIALS

Granules India Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Granules India Ltd

  • C Krishna Prasad
  • Chairman & Managing Director
  • A Arun Rao Akinepally
  • Non-Exec. & Independent Dir.
  • Harsha Chigurupati
  • Executive Director
  • Uma Devi Chigurupati
  • Executive Director
  • K B Sankara Rao
  • Non-Exec & Non-Independent Dir
  • Chaitanya Tummala
  • Company Sec. & Compli. Officer
  • Arun Sawhney
  • Non-Exec. & Independent Dir.
  • Saumen Chakraborty
  • Independent Director
  • Sucharita Rao Palepu
  • Independent Director
  • KVS Ram Rao
  • Joint Managing Director & CEO
  • Kapil Mehan
  • Independent Director
  • Rajiv Kakodkar
  • Additional Director

Summary

Granules India Limited is a large-scale vertically integrated company founded in March 18th, 1991 manufacturing Active Pharmaceutical Ingredient (API), Pharmaceutical Formulation Intermediate (PFI) and Finished Dosage (FD). With a strong presence across all three vertical, the company has created a leadership position in the off-patent drugs segment along with ensuring a strong presence in first line of defense products such as Paracetamol, Ibuprofen, Metformin and Guaifenesin. The company has a global presence across over 80 countries servicing over 300 customers. Granules India is the preferred supplier for some of the worlds leading pharma branded and generics companies. The company has one of largest PFI and single site FD facilities in the world. It is also home to one of the Worlds largest Paracetamol API facilities.Granules India has 8 manufacturing facilities, out of which six are located in India and two in the US. It also has two operational manufacturing units located in India and China through its joint venture entities. The company has 250 customers present across 60 countries around the globe. The companys research center at Pragathi Nagar, Hyderabad, spread across an area of 15,000 square feet, epitomizes the companys focus on research and development. It mainly focuses on full-scale generic API development.Incorporated as a private limited company in 1991, Granules India (GIL) was converted into a public limited company in Feb.93. It commenced its operations... Read More


Reports by Granules India Ltd


Reports by Granules India Ltd

Company FAQ

No Record Found